A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: The Fudan score

Annals of Oncology

Volumn 22, Issue 7, 2011, Pages 1644-1652

  Jiang, W ^a   Zeng, Z C ^a   Tang, Z Y ^a   Fan, J ^a   Sun, H C ^a   Zhou, J ^a   Zeng, M S ^a   Zhang, B H ^a   Ji, Y ^a   Chen, Y X ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Clinical features; Intrahepatic cholangiocarcinoma; Prognosis; Scoring system

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN;

AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FUDAN SCORE; HEPATITIS B; HUMAN; INTRAHEPATIC BILE DUCT; LAPAROTOMY; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHISTOSOMIASIS; SCORING SYSTEM; SURVIVAL TIME; TUMOR VOLUME;

EID: 79959729028     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq650     Document Type: Article

References (25)

1. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003; 10: 288-291.
2. Giuliante F, Gauzolino R, Vellone M et al. Liver resection for intrahepatic cholangiocarcinoma. Tumori 2005; 91: 487-492.
3. Olnes MJ, Erlich R. A review and update on cholangiocarcinoma. Oncology 2004; 66: 167-179.
4. Nathan H, Aloia TA, Vauthey JN et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009; 16: 14-22.
5. Okabayashi T, Yamamoto J, Kosuge T et al. A new staging system for massforming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001; 92: 2374-2383.
6. Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2010; 26: 269-273.
7. Eun JR, Jang BI, Lee JY et al. Clinical characteristics of intrahepatic cholangiocarcinoma and prognostic factors in patients who received non-surgical treatment. Korean J Gastroenterol 2009; 54: 227-234.
8. Bi AH, Zeng ZC, Ji Y et al. Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume. Int J Radiat Oncol Biol Phys 2010; 78(5): 1427-1436.
9. Paik KY, Jung JC, Heo JS et al. What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 2008; 23: 766-770.
10. Endo I, Gonen M, Yopp AC et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008; 248: 84-96.
11. Davison AC, Hinkley DV. Bootstrap Methods and Their Application. Cambridge: Cambridge University Press 1997.
12. Lee TY, Lee SS, Jung SW et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 2008; 103: 1716-1720.
13. Jiang BG, Sun LL, Yu WL et al. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma. Cancer J 2009; 15: 257-261.
14. Zhou XD, Tang ZY, Fan J et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2009; 135: 1073-1080.
15. Miwa S, Miyagawa S, Kobayashi A et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 2006; 41: 893-900.
16. Nakagawa T, Kamiyama T, Kurauchi N et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005; 29: 728-733.
17. Roayaie S, Guarrera JV, Ye MQ et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998; 187: 365-372.
18. Nakagohri T, Kinoshita T, Konishi M et al. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg 2008; 32: 2675-2680.
19. Aishima S, Kuroda Y, Nishihara Y et al. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 2007; 31: 1059-1067.
20. Morimoto Y, Tanaka Y, Ito T et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003; 10: 432-440.
21. Nanashima A, Shibata K, Nakayama T et al. Relationship between microvessel count and postoperative survival in patients with intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009; 16: 2123-2129.
22. Ohtsuka M, Ito H, Kimura F et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89: 1525-1531.
23. Shen WF, Zhong W, Xu F et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 2009; 15: 5976-5982.
24. Heimbach JK, Gores GJ, Haddock MG et al. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 2006; 82: 1703-1707.
25. Bhudhisawasdi V, Muisuk K, Areejitranusorn P et al. Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma. J Cancer Res Clin Oncol 2004; 130: 87-92.